Sionna Therapeutics Inc (SION)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||
| Net Income | -61,688 | -47,263 |
| Depreciation Amortization | -2,333 | -96 |
| Accounts payable and accrued liabilities | 467 | 162 |
| Other Working Capital | -3,075 | -783 |
| Other Operating Activity | 13,842 | 4,281 |
| Operating Cash Flow | $-52,787 | $-43,699 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -126,886 | 28,468 |
| PPE Investments | -27 | -1,116 |
| Investing Cash Flow | $-126,913 | $27,352 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 141 | 31 |
| Other Financing Activity | 178,826 | 0 |
| Financing Cash Flow | $178,967 | $31 |
| Beginning Cash Position | 39,483 | 55,799 |
| End Cash Position | 38,750 | 39,483 |
| Net Cash Flow | $-733 | $-16,316 |
| Free Cash Flow | ||
| Operating Cash Flow | -52,787 | -43,699 |
| Capital Expenditure | -27 | -1,116 |
| Free Cash Flow | -52,814 | -44,815 |